BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

OREXO US, INC. — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

OREXO US, INC.

via CONNECT 4 STRATEGIES, LLC

3rd Quarter (July 1 - Sep 30) · 2022Posted Oct 19, 2022Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: OREXO US, INC.
Description: Pharmaceutical Company
Location: New Jersey · United States of America

Registrant

Firm: CONNECT 4 STRATEGIES, LLC
Description: Strategic Consulting
Location: White Stone, Virginia, United States of America

Lobbying activities

1 issue

Pharmacy
Medicare, Medicaid and Healthcare.
LobbyistsSAIRA SULTAN CHIRICO
Covered position (SAIRA SULTAN CHIRICO): US Senate HELP Committee, Employment Subcommittee, Chief Counsel
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.